EFFECTS OF THE TYPE 2 DIABETES-ASSOCIATED PPARG P12A POLYMORPHISM ON PROGRESSION TO DIABETES AND RESPONSE TO TROGLITAZONE

CONTEXT: The common P12A polymorphism in PPARG (a target for thiazolidinedione medications) has been consistently associated with type 2 diabetes. OBJECTIVE: We examined whether PPARG P12A affects progression from impaired glucose tolerance (IGT) to diabetes, or responses to preventive interventions...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Florez, Jose C., Jablonski, Kathleen A., Sun, Maria W., Bayley, Nick, Kahn, Steven E., Shamoon, Harry, Hamman, Richard F., Knowler, William C., Nathan, David M., Altshuler, David
Formato: Artigo
Lenguaje:Inglês
Publicado: 2007
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2267936/
https://ncbi.nlm.nih.gov/pubmed/17213274
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2006-2275
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares